Case number 2015-2063
Merck & Cie v. Watson Laboratories Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | MERCK & CIE v. WATSON LABORATORIES INC. [OPINION] [precedential] (0) |
| Jan 9, 2017 | 63 | The petition for writ of certiorari [16-493] filed on 10/12/2016, was Denied on 01/09/2017. [397239] [15-2063, 15-2064] [JCA] [Entered: 01/09/2017 04:11 PM] (1) |
| Oct 20, 2016 | 62 | Petition for writ of Certiorari filed on 10/12/2016 in the Supreme Court of the United States. Supreme Court #: 16-493, Merck & Cie v. Watson Laboratories Inc.. [376223] [15-2063, 15-2064] [JCA] [Entered: 10/20/2016 01:14 PM] (1) |
| Jul 29, 2016 | 61 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [354491] [15-2063, 15-2064] [JCA] [Entered: 07/29/2016 09:18 AM] (1) |
| Jul 27, 2016 | 60 | Order from the Supreme Court of the United States vacating the stay of 7/21/2016 and denying the application for stay in all respects. [354009] [15-2063, 15-2064] [IW] [Entered: 07/27/2016 01:06 PM] (1) |
| Jul 21, 2016 | 59 | Clerk's Note to the File: Pursuant to the order of the Supreme Court of the United States [58], the issuance of the mandate is stayed. [352697] [15-2063, 15-2064] [IW] [Entered: 07/21/2016 03:26 PM] (0) |
| Jul 21, 2016 | 58 | Notice from the Supreme Court of the United States: Order from the SC staying issuance of our mandate in these appeals. Mandate was scheduled to issue 7/22/16 (tomorrow). [352677] [15-2063, 15-2064] [JCA] [Entered: 07/21/2016 02:53 PM] (1) |
| Jul 19, 2016 | 57 | ORDER filed denying [56] motion to stay mandate filed by Bayer Pharma AG, Merck & Cie and Bayer HealthCare Pharmaceuticals Inc.. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [352033] [JCA] [Entered: 07/19/2016 03:22 PM] (2) |
| Jul 18, 2016 | 56 | MOTION of Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie to stay execution of the mandate until the Supreme Court has reviewed Appellees' forthcoming petition for a writ of certiorari. Response/Opposition is due 08/01/2016 [Consent: not addressed]. Service: 07/18/2016 by email. [351782] [John McBride] [Entered: 07/18/2016 10:44 PM] (41) |
| Jul 15, 2016 | 55 | ORDER filed denying [53] petition for panel rehearing, denying [53] petition for en banc rehearing filed by Bayer Pharma AG, Merck & Cie and Bayer HealthCare Pharmaceuticals Inc. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [351175] [SJ] [Entered: 07/15/2016 01:08 PM] (2) |
| Jun 15, 2016 | 54 | 18 paper copies of the petition for panel rehearing [53], petition for en banc rehearing [53] received from Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. [343654] [LAJ] [Entered: 06/15/2016 09:49 AM] (0) |
| Jun 13, 2016 | 53 | Petition for panel rehearing, for en banc rehearing filed by Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 06/13/2016 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 06/15/2016 [343119] [John McBride] [Entered: 06/13/2016 05:06 PM] (30) |
| May 13, 2016 | 52 | OPINION and JUDGMENT filed. The judgment or decision is: Reversed. (Precedential Opinion). (For the Court: Dyk,Circuit Judge; Mayer,Circuit Judge and Hughes,Circuit Judge). [334806] [15-2063, 15-2064] [JCA] [Entered: 05/13/2016 09:21 AM] (18) |
| Mar 8, 2016 | 51 | RESPONSE of Appellant Watson Laboratories Inc. to the supplemental authority [50] filed by Appellees Bayer Pharma AG, Merck & Cie and Bayer HealthCare Pharmaceuticals Inc. in 15-2063. Service: 03/08/2016 by email. [316868] [Steven Maddox] [Entered: 03/08/2016 04:42 PM] (3) |
| Mar 7, 2016 | 50 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 03/07/2016 by email. [316490] [John McBride] [Entered: 03/07/2016 05:34 PM] (2) |
| Feb 8, 2016 | 49 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 02/08/2016 by email. [309273] [John McBride] [Entered: 02/08/2016 12:28 PM] (3) |
| Feb 2, 2016 | 48 | Submitted after ORAL ARGUMENT by Mr. Steven Arthur Maddox for Watson Laboratories Inc. and Mr. John Scott McBride for Bayer Pharma AG, Merck & Cie and Bayer HealthCare Pharmaceuticals Inc.. Panel: Judge: Dyk , Judge: Mayer , Judge: Hughes. [307733] [LAJ] [Entered: 02/02/2016 10:33 AM] (0) |
| Jan 14, 2016 | 47 | Response to oral argument order from the Appellant Watson Laboratories Inc.. designating Steven A. Maddox as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [302877] [Steven Maddox] [Entered: 01/14/2016 11:41 AM] (0) |
| Jan 12, 2016 | 46 | Response to oral argument order from the Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. designating J. Scott McBride as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [302161] [John McBride] [Entered: 01/12/2016 11:52 AM] (0) |
| Dec 18, 2015 | 45 | NOTICE OF CALENDARING. Panel: 1602F. Case scheduled Feb 02, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 203. Response to oral argument order due: 01/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [297452] THIS NOTICE APPLIES TO CASE(S): [15-1375, 15-1596, 15-2063, 15-5097] [JAB] [Entered: 12/18/2015 12:58 PM] (0) |
| Dec 7, 2015 | 44 | Notice from Appellant Watson Laboratories Inc. regarding conflicts with oral argument (January 25-29, 2016). Service: 12/07/2015 by email. [294033] [Steven Maddox] [Entered: 12/07/2015 12:02 PM] (1) |
| Dec 7, 2015 | 43 | NOTICE OF DEFICIENCY: The party letter Document No. [42] filed by Appellant Watson Laboratories Inc. in 15-2063 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. The correct event is: NOTICE FROM PARTY REGARDING ORAL ARGUMENT (ntc frm pty re OA). You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [293922] [JW] [Entered: 12/07/2015 09:48 AM] (0) |
| Dec 4, 2015 | 42 | Notice from Appellant Watson Laboratories Inc. regarding conflicts with oral argument (January 25-29, 2016). Service: 12/04/2015 by email. [293793] [Steven Maddox] [Entered: 12/04/2015 05:13 PM] (0) |
| Nov 30, 2015 | 41 | Notice from Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie regarding conflicts with oral argument (January 4-6, 2016). Service: 11/30/2015 by email. [292237] [Adam Mortara] [Entered: 11/30/2015 12:49 PM] (1) |
| Nov 30, 2015 | 40 | 6 paper copies of the Joint Appendix [38] received from Appellant Watson Laboratories Inc.. [292174] [MJL] [Entered: 11/30/2015 11:00 AM] (0) |
| Nov 30, 2015 | 39 | 6 paper copies of the Reply Brief [37] received from Appellant Watson Laboratories Inc.. [292150] [MJL] [Entered: 11/30/2015 10:40 AM] (0) |
| Nov 24, 2015 | 38 | APPENDIX FILED for Watson Laboratories Inc. [36]. Number of Pages: 265. Service: 11/24/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 11/30/2015. [291756] [JCA] [Entered: 11/25/2015 09:51 AM] (265) |
| Nov 24, 2015 | 37 | REPLY BRIEF FILED for Appellant Watson Laboratories Inc. [35]. Number of Pages: 29. Service: 11/24/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 11/30/2015. [291720] [JCA] [Entered: 11/25/2015 08:59 AM] (38) |
| Nov 24, 2015 | 36 | TENDERED from Appellant Watson Laboratories Inc. and Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Title: JOINT APPENDIX. Service: 11/24/2015 by email. [291697] [Steven Maddox] [Entered: 11/24/2015 06:27 PM] (265) |
| Nov 24, 2015 | 35 | TENDERED from Appellant Watson Laboratories Inc.. Title: REPLY BRIEF. Service: 11/24/2015 by email. [291696] [Steven Maddox] [Entered: 11/24/2015 06:21 PM] (38) |
| Nov 24, 2015 | 34 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Watson Laboratories Inc. and Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 11/24/2015 by email. [291695] [Steven Maddox] [Entered: 11/24/2015 06:13 PM] (3) |
| Nov 23, 2015 | 33 | 6 paper copies of the Opening Response Brief [32] received from Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. [290993] [JW] [Entered: 11/23/2015 01:08 PM] (0) |
| Nov 17, 2015 | 32 | BRIEF FILED for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie [31]. Number of Pages: 55. Service: 11/17/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 11/23/2015. Pursuant to the order issued on October 16, 2015, appellant's reply brief and joint appendix due November 24, 2015 [289618] [JW] [Entered: 11/18/2015 09:47 AM] (69) |
| Nov 17, 2015 | 31 | TENDERED from Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Title: RESPONSE BRIEF. Service: 11/17/2015 by email. [289522] [John McBride] [Entered: 11/17/2015 04:30 PM] (69) |
| Nov 9, 2015 | 30 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Watson Laboratories Inc.. Service: 11/09/2015 by email. [287404] [Steven Maddox] [Entered: 11/09/2015 03:44 PM] (3) |
| Nov 9, 2015 | 29 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 11/09/2015 by email, clerk. [287323] [John McBride] [Entered: 11/09/2015 01:02 PM] (3) |
| Oct 22, 2015 | 28 | 6 paper copies of the Opening Brief [27] received from Appellant Watson Laboratories Inc.. [283379] [LAJ] [Entered: 10/26/2015 12:19 PM] (0) |
| Oct 20, 2015 | 27 | BRIEF FILED for Appellant Watson Laboratories Inc. [26]. Number of Pages: 57. Service: 10/20/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 10/26/2015. [282143] [JCA] [Entered: 10/21/2015 09:36 AM] (108) |
| Oct 20, 2015 | 26 | TENDERED from Appellant Watson Laboratories Inc.. Title: OPENING BRIEF. Service: 10/20/2015 by email. [282098] [Steven Maddox] [Entered: 10/20/2015 07:06 PM] (108) |
| Oct 20, 2015 | 25 | Amended Certificate of Interest for the Appellant Watson Laboratories Inc.. Service: 10/20/2015 by email. [282090] [Steven Maddox] [Entered: 10/20/2015 06:31 PM] (2) |
| Oct 16, 2015 | 24 | Entry of appearance for Kaveh Saba as of counsel for Appellant Watson Laboratories Inc.. Service: 10/16/2015 by email. [281149] [Steven Maddox] [Entered: 10/16/2015 06:45 PM] (2) |
| Oct 16, 2015 | 23 | ORDER filed granting motion to expedite briefing schedule [6] [275780-2] to the extent that the appellees must file their responsive brief no later than November 17, 2015. Watson's reply brief and the joint appendix are due no later than November 24, 2015. The case will be placed on the next available oral argument calendar after briefing is complete. Service: 10/16/2015 by clerk. [280842] [15-2063, 15-2064] [LMS] [Entered: 10/16/2015 08:19 AM] (2) |
| Oct 8, 2015 | 22 | Docketing Statement for the Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 10/08/2015 by email, clerk. [278923] [John McBride] [Entered: 10/08/2015 03:05 PM] (4) |
| Oct 8, 2015 | 21 | Docketing Statement for the Appellant Watson Laboratories Inc.. Service: 10/08/2015 by email. [278818] [Steven Maddox] [Entered: 10/08/2015 12:57 PM] (6) |
| Oct 5, 2015 | 20 | RESPONSE of Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie to the motion to expedite briefing schedule [6] filed by Appellant Watson Laboratories Inc. in 15-2063 , motion to expedite hearing [6] filed by Appellant Watson Laboratories Inc. in 15-2063. Service: 10/05/2015 by email, clerk. [277544] [John McBride] [Entered: 10/05/2015 12:21 PM] (7) |
| Oct 5, 2015 | 19 | Certificate of Interest for the Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 10/05/2015 by email, clerk. [277543] [John McBride] [Entered: 10/05/2015 12:15 PM] (2) |
| Oct 5, 2015 | 18 | Entry of appearance for Faye E. Paul as of counsel for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 10/05/2015 by email, clerk. [277541] [Faye Paul] [Entered: 10/05/2015 12:11 PM] (2) |
| Oct 5, 2015 | 17 | Entry of appearance for Rebecca T. Horwitz as of counsel for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 10/05/2015 by email, clerk. [277540] [Rebecca Horwitz] [Entered: 10/05/2015 12:09 PM] (2) |
| Oct 5, 2015 | 16 | Entry of appearance for J. Scott McBride as of counsel for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 10/05/2015 by email, clerk. [277537] [John McBride] [Entered: 10/05/2015 12:07 PM] (2) |
| Oct 5, 2015 | 15 | Entry of appearance for Adam K. Mortara as principal counsel for Appellees Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma AG and Merck & Cie. Service: 10/05/2015 by email, clerk. [277536] [Adam Mortara] [Entered: 10/05/2015 12:04 PM] (2) |
| Sep 29, 2015 | 14 | Corrected Entry of appearance for Matthew C. Ruedy as of counsel for Appellant Watson Laboratories Inc.. Service: 09/29/2015 by email. [276196] [Steven Maddox] [Entered: 09/29/2015 04:35 PM] (2) |
| Sep 29, 2015 | 13 | Corrected Entry of appearance for Jeremy J. Edwards as of counsel for Appellant Watson Laboratories Inc.. Service: 09/29/2015 by email. [276195] [Steven Maddox] [Entered: 09/29/2015 04:34 PM] (2) |
| Sep 29, 2015 | 12 | Corrected Entry of appearance for Steven A. Maddox as principal counsel for Appellant Watson Laboratories Inc.. Service: 09/29/2015 by email. [276192] [Steven Maddox] [Entered: 09/29/2015 04:33 PM] (2) |
| Sep 29, 2015 | 11 | ORDER filed. Appellees are directed to file a consolidated response to the motions [6] [275780-2] no later than October 5, 2015. Watson's consolidated opening brief is due no later than October 20, 2015. Service: 09/29/2015 by clerk. [276160] [15-2063, 15-2064] [LMS] [Entered: 09/29/2015 04:06 PM] (2) |
| Sep 29, 2015 | 10 | Note to file: The following cases are associated:15-2063 Lead with 15-2064 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [276109] [JW] [Entered: 09/29/2015 03:11 PM] (0) |
| Sep 29, 2015 | 9 | ORDER consolidating appeals (15-2063 Lead with 15-2064 Consolidated). Service as of this date by Clerk of Court. [276104] [15-2063, 15-2064] [JW] [Entered: 09/29/2015 03:07 PM] (2) |
| Sep 29, 2015 | 8 | NOTICE OF DEFICIENCY: The attorney entry of appearance for MATTHEW C. RUEDY Document No. [4] filed by Appellant Watson Laboratories Inc. in 15-2063 indicates a law firm affiliation which does not match Mr. Ruedy's ECF account. The ECF account identifies Kenyon & Kenyon as counsel's firm affiliation. The entry of appearance cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. CLERK'S NOTE: Counsel's ECF account may be updated at www.pacer.gov "Manage My Appellate Filer Account". At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [276023] [AT] [Entered: 09/29/2015 12:58 PM] (0) |
| Sep 29, 2015 | 7 | NOTICE OF DEFICIENCY: The attorney entries of appearance Document Nos. [4] [3] [2] filed by Appellant Watson Laboratories Inc. in 15-2063 are without a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. CLERK'S NOTE: The required certificate of service may be filed using the ECF event "Corrected Certificate of Service." At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [276020] [AT] [Entered: 09/29/2015 12:53 PM] (0) |
| Sep 28, 2015 | 6 | MOTION of Appellant Watson Laboratories Inc. to expedite briefing schedule. Response/Opposition is due 10/13/2015, to expedite hearing. Response/Opposition is due 10/13/2015 [Consent: opposed]. Service: 09/28/2015 by email, US mail. [275774] [Steven Maddox] [Entered: 09/28/2015 04:39 PM] (32) |
| Sep 28, 2015 | 5 | Certificate of Interest for the Appellant Watson Laboratories Inc.. Service: 09/28/2015 by email, US mail. [275767] [Steven Maddox] [Entered: 09/28/2015 04:28 PM] (3) |
| Sep 28, 2015 | 4 | Entry of appearance for Matthew C. Ruedy as of counsel for Appellant Watson Laboratories Inc.. Service: 09/28/2015 by email, US mail. [275766] [Steven Maddox] [Entered: 09/28/2015 04:27 PM] (1) |
| Sep 28, 2015 | 3 | Entry of appearance for Jeremy J. Edwards as of counsel for Appellant Watson Laboratories Inc.. Service: 09/28/2015 by email, US mail. [275765] [Steven Maddox] [Entered: 09/28/2015 04:26 PM] (1) |
| Sep 28, 2015 | 2 | Entry of appearance for Steven A. Maddox as principal counsel for Appellant Watson Laboratories Inc.. Service: 09/28/2015 by email, US mail. [275764] [Steven Maddox] [Entered: 09/28/2015 04:25 PM] (1) |
| Sep 24, 2015 | 1 | Appeal docketed. Received: 09/21/2015. [274862]Entry of Appearance due 10/08/2015. Certificate of Interest is due on 10/08/2015. Docketing Statement due 10/08/2015. Appellant/Petitioner's brief is due 11/23/2015. [SJ] [Entered: 09/24/2015 02:29 PM] (37) |
